Value of ultrasound BI‑RADS classification in preoperative evaluation of the ultrasound‑guided Mammotome‑assisted minimally invasive resection of breast masses: A retrospective analysis

Abstract

The American College of Radiology Breast Imaging Reporting and Data System (BI-RADS) classification has been used for the diagnosis of breast masses for several decades and constantly updated, but the terminology used to describe breast ultrasound findings is still evolving and a great amount of large sample data is necessary to verify and improve ultrasound BI-RADS. The objective of the present study was to explore the value of ultrasound Breast Imaging Reporting and Data System (US BI-RADS) classification in the preoperative evaluation of the US-guided Mammotome-assisted minimally invasive resection of breast masses. A total of 1,028 patients with 1,341 breast masses from a single hospital were selected for retrospective analysis. All patients underwent minimally invasive resection using a US-guided Mammotome device, and postoperative pathological examinations were performed for all samples. The preoperative US BI-RADS classification and postoperative pathological examination results were compared and analyzed. A receiver operating characteristic (ROC) curve was used to analyze the preoperative evaluation efficacy of the US BI-RADS classification in US-guided Mammotome-assisted minimally invasive breast mass resection. Among the 1,341 breast masses that underwent resection, 1,307 were benign and 34 were malignant. The specificity, sensitivity, accuracy, positive predictive value and negative predictive value of the US BI-RADS classification in the preoperative diagnosis of malignant breast masses were 83.47, 100.00, 83.89, 13.60 and 100.00%, respectively, and the area under the ROC curve was 0.917. It may be concluded that the US BI-RADS classification has a good preoperative diagnostic performance and can provide an accurate assessment prior to Mammotome-assisted minimally invasive resection. It may help surgeons to make reasonable decisions for subsequent therapy and therefore is worthy of further clinical use.

The efficacy of norepinephrine application in Mammotome-assisted minimally invasive resection for benign breast neoplasm: A retrospective study Running title：norepinephrine application in benign breast neoplasm

“…For the diagnosis and treatment of benign breast nodules, surgical resection is the main approach. Importantly, the gradual promotion of MAMIR has bene ted the majority of female patients [11] .…”

“…The need for written informed consent was waived by the Xishan People's Hospital of Wuxi City Ethics Committee due to the retrospective nature of the study (No. xs2024ky001) Inclusion criteria were the following (1) those who underwent MAMIR either non-NPP or NPP; (2) aged 18-75 years; (3) with benign breast nodules by physical examination, color ultrasound, mammography and histopathology according to bi-RADS classi cation criteria [11] ; (4) the diameter of a single nodule no more than 3cm (≤ 3cm).…”

Radiomics analysis based on semi-automatic image segmentation of ultrasound for preoperative evaluation of Mammotome-assisted minimally invasive resection

“…However, it is still an invasive surgery that may cause different degrees of breast tissue damage. Therefore, precise pre-operative evaluation of breast masses during Mammotome-assisted minimally invasive resection is crucial for doctors to develop appropriate surgical plans and avoid overtreatment or unnecessary treatment 8,9 .…”

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

“…The patient was a 33-year-old female who exhibited bilateral breast lumps on ultrasound, categorized as BI-RADS 4, with relatively large-sized lumps (Figure 1). Histopathological confirmation through Mammotome-assisted minimally invasive resection identified bilateral ductal carcinoma in situ 14 (Figure 2). This young woman had bilateral nipple asymmetry and a strong desire to rectify it.…”